Augere Medical

About Augere Medical

Augere Medical is a company focused on commercializing the PolypAID™ platform, an AI-assisted colonoscopy guidance system aimed at enhancing the detection of polyps during colonoscopies with an emphasis on quality, agility, and delivering results.

Products & Services

PolypAID™:A medical technology platform designed to assist endoscopists by aiding in the detection of adenomas, sessile serrated lesions, and hyperplastic polyps in the colon.

Specialties

AI-assisted colonoscopy Polyp detection Endoscopy support technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: First Close T: - FT: First Close	A: 2100000 MR: - FA: NOK 23M FAN: 2100000	D: 2024-11-19 FD: 2024-11-19	2 investors

First Close Latest

2024-11-19

$2.1M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael Riegler

Scientific Advisor

LinkedIn (Pro only)

T

Thomas de Lange

Chief Medical Scientist

LinkedIn (Pro only)

N

N. Papachrysos

P

P. H. Smedsrud

K

K. Anonsen

T

T. J. Berstad

View 30 more team members with Pro

Unlock Full Team Directory

Recent News

Augere Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised